Effects of Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) Patients

Inclusion Criteria: * PCO - Androgen Excess Society criteria: hyperandrogenism (hirsutism) / hyperandrogenemia (testosterone \>70ng/dl) and/or oligomenorrhea (\<8 spontaneous menses per year) and/or polycystic ovarian morphology on ultrasound * Normal prolactin, TSH, 17-OH progesterone * No evidence of androgen producing malignancy, Cushing's syndrome or acromegaly * Age 18-40 Exclusion Criteria: * Use of oral contraceptives and/or other steroid hormones 3 months prior to the study